SLP (Simulations Plus) Short Interest

View and export this data going back to 1997. Start your Free Trial

What is Simulations Plus Short Interest?

Short Interest can be expressed as a percentage by dividing the number of shares sold short by the total number of outstanding shares.

Due to the license agreement change with our data vendor, Short Interest related data is no longer available on GuruFocus website.

Competitive Comparison of Simulations Plus's Short Interest

For the Health Information Services subindustry, Simulations Plus's Short Interest, along with its competitors' market caps and Short Interest data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Simulations Plus's Short Interest Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Simulations Plus's Short Interest distribution charts can be found below:

* The bar in red indicates where Simulations Plus's Short Interest falls into.

Save Embed

;

Save Embed

;

Simulations Plus Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Simulations Plus Inc (NAS:SLP) » Definitions » Short Interest

Comparable Companies

Traded in Other Exchanges

N/A

Address

42505 Tenth Street West, Lancaster, CA, USA, 93534-7059

Website

https://www.simulations-plus.com

Simulations Plus Inc is engaged in the software industry. It includes two segments. It develops and produces software for use in pharmaceutical research and education, and provides consulting and contract research services to the pharmaceutical industry. The company's operating segments include Software and services. The company offers software products for pharmaceutical research such as ADMET (Absorption, Distribution, Metabolism, Excretion, and Toxicity). It generates maximum revenue from the software segment. Maximum revenue is earned from USA following EMEA and Asia Pacific.

Executives

Walter S Woltosz	director, 10 percent owner, officer: Chairman and CEO	42505 10TH ST. WEST, LANCASTER CA 93534
Daniel L Weiner	director	800 WEST EL CAMINO REAL, SUITE 200, MOUNTAIN VIEW CA 94040
Lisa Lavange	director	42505 10TH ST., WEST, LANCASTER CA 93534
John Kenneth Paglia	director	746 GRABLE PLACE, NEWBURY PARK CA 91320
Dibella John Anthony Ii	officer: Division President	42505 10TH STREET WEST, LANCASTER CA 93534
Steven Chang	officer: President, Immunetrics	42505 10TH STREET WEST, LANCASTER CA 15203
Shawn Oconnor	officer: Chief Executive Officer	42505 10TH STREET WEST, LANCASTER CA 93534-7059
Jill Fiedler-kelly	officer: President, Cognigen Division	42505 10TH STREET WEST, LANCASTER CA 93534
Brett Howell	officer: President, DILIsym Division	42505 10TH STREET WEST, LANCASTER CA 93534
William W Frederick	officer: CFO	C/O SIMULATIONS PLUS, INC., 42505 10TH STREET WEST, LANCASTER CA 93534
Sharlene Evans	director	42505 10TH STREET WEST, LANCASTER CA 93534
Nguyen Nguyen	officer: VP of Human Resources	42505 TENTH STREET WEST, LANCASTER CA 93534
David L. Ralph	director	42505 10TH STREET WEST, LANCASTER CA 93534
John Robert Kneisel	officer: CFO	42505 10TH STREET WEST, LANCASTER CA 93534
Grasela Thaddeus Henry Jr	director, officer: President	1780 WEHRLE DRIVE SUITE 110, BUFFALO NY 14221